US Stock MarketDetailed Quotes

TSBX Turnstone Biologics

Watchlist
  • 0.510
  • -0.026-4.83%
Close Oct 2 16:00 ET
11.80MMarket Cap-157P/E (TTM)

Turnstone Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-73.66%19.31M
0
0
0
80.13%19.31M
-27.64%73.3M
10.45M
10.22M
Operating revenue
--0
--0
-73.66%19.31M
--0
--0
--0
80.13%19.31M
-27.64%73.3M
--10.45M
--10.22M
Cost of revenue
Gross profit
Operating expense
0.94%22.06M
5.03%20.69M
-25.34%78.34M
-27.32%17.86M
-28.54%18.93M
-28.28%21.85M
-15.81%19.7M
53.63%104.93M
24.57M
26.49M
Selling and administrative expenses
-7.13%4.33M
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
--5.24M
-General and administrative expense
-7.13%4.33M
21.55%4.9M
-2.06%17.85M
1.03%4.4M
-9.20%4.76M
18.49%4.66M
-14.18%4.03M
34.53%18.22M
--4.35M
--5.24M
Research and development costs
3.12%17.73M
0.78%15.79M
-30.23%60.49M
-33.42%13.46M
-33.31%14.17M
-35.21%17.19M
-16.22%15.67M
58.35%86.7M
--20.21M
--21.25M
Operating profit
-0.94%-22.06M
-5,151.52%-20.69M
-86.66%-59.03M
-26.46%-17.86M
-16.34%-18.93M
-290.91%-21.85M
96.89%-394K
-195.86%-31.63M
-14.12M
-16.27M
Net non-operating interest income expense
Other net income (expense)
117.58%755K
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
468K
200K
Other non- operating income (expenses)
117.58%755K
183.68%1.08M
280.06%3.55M
165.17%1.24M
689.00%1.58M
92.78%347K
347.06%380K
31.78%933K
--468K
--200K
Income before tax
0.94%-21.3M
-139,992.86%-19.61M
-80.78%-55.49M
-21.70%-16.62M
-7.97%-17.35M
-284.97%-21.51M
99.89%-14K
-191.07%-30.69M
-13.65M
-16.07M
Income tax
133.33%2K
119.51%16K
-302.84%-286K
-1,200.00%-165K
-141.25%-33K
-123.08%-6K
-510.00%-82K
-67.36%141K
15K
80K
Net income
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
-16.15M
Net income continuous Operations
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
---13.67M
---16.15M
Minority interest income
Net income attributable to the parent company
0.91%-21.3M
-28,966.18%-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
100.54%68K
-192.68%-30.83M
-13.67M
-16.15M
Preferred stock dividends
Other preferred stock dividends
0
68K
Net income attributable to common stockholders
0.91%-21.3M
-19.63M
-79.02%-55.2M
-20.36%-16.45M
-7.23%-17.32M
-285.34%-21.5M
0
-192.68%-30.83M
-13.67M
-16.15M
Basic earnings per share
5.05%-0.92
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
-0.7279
Diluted earnings per share
5.05%-0.92
-0.85
-243.98%-4.78
-18.52%-0.73
-37.38%-1
-285.34%-0.9689
0
-192.68%-1.3896
-0.6159
-0.7279
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-73.66%19.31M00080.13%19.31M-27.64%73.3M10.45M10.22M
Operating revenue --0--0-73.66%19.31M--0--0--080.13%19.31M-27.64%73.3M--10.45M--10.22M
Cost of revenue
Gross profit
Operating expense 0.94%22.06M5.03%20.69M-25.34%78.34M-27.32%17.86M-28.54%18.93M-28.28%21.85M-15.81%19.7M53.63%104.93M24.57M26.49M
Selling and administrative expenses -7.13%4.33M21.55%4.9M-2.06%17.85M1.03%4.4M-9.20%4.76M18.49%4.66M-14.18%4.03M34.53%18.22M--4.35M--5.24M
-General and administrative expense -7.13%4.33M21.55%4.9M-2.06%17.85M1.03%4.4M-9.20%4.76M18.49%4.66M-14.18%4.03M34.53%18.22M--4.35M--5.24M
Research and development costs 3.12%17.73M0.78%15.79M-30.23%60.49M-33.42%13.46M-33.31%14.17M-35.21%17.19M-16.22%15.67M58.35%86.7M--20.21M--21.25M
Operating profit -0.94%-22.06M-5,151.52%-20.69M-86.66%-59.03M-26.46%-17.86M-16.34%-18.93M-290.91%-21.85M96.89%-394K-195.86%-31.63M-14.12M-16.27M
Net non-operating interest income expense
Other net income (expense) 117.58%755K183.68%1.08M280.06%3.55M165.17%1.24M689.00%1.58M92.78%347K347.06%380K31.78%933K468K200K
Other non- operating income (expenses) 117.58%755K183.68%1.08M280.06%3.55M165.17%1.24M689.00%1.58M92.78%347K347.06%380K31.78%933K--468K--200K
Income before tax 0.94%-21.3M-139,992.86%-19.61M-80.78%-55.49M-21.70%-16.62M-7.97%-17.35M-284.97%-21.51M99.89%-14K-191.07%-30.69M-13.65M-16.07M
Income tax 133.33%2K119.51%16K-302.84%-286K-1,200.00%-165K-141.25%-33K-123.08%-6K-510.00%-82K-67.36%141K15K80K
Net income 0.91%-21.3M-28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M-13.67M-16.15M
Net income continuous Operations 0.91%-21.3M-28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M---13.67M---16.15M
Minority interest income
Net income attributable to the parent company 0.91%-21.3M-28,966.18%-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M100.54%68K-192.68%-30.83M-13.67M-16.15M
Preferred stock dividends
Other preferred stock dividends 068K
Net income attributable to common stockholders 0.91%-21.3M-19.63M-79.02%-55.2M-20.36%-16.45M-7.23%-17.32M-285.34%-21.5M0-192.68%-30.83M-13.67M-16.15M
Basic earnings per share 5.05%-0.92-0.85-243.98%-4.78-18.52%-0.73-37.38%-1-285.34%-0.96890-192.68%-1.3896-0.6159-0.7279
Diluted earnings per share 5.05%-0.92-0.85-243.98%-4.78-18.52%-0.73-37.38%-1-285.34%-0.96890-192.68%-1.3896-0.6159-0.7279
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data